Stress Intervention for Chronic Urticaria
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01111136|
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : November 25, 2010
|Condition or disease||Intervention/treatment||Phase|
|Chronic Urticaria||Behavioral: Stress intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Effect of Psychological Stress Intervention for Patients With Chronic Urticaria|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||July 2010|
|Actual Study Completion Date :||July 2010|
Experimental: stress intervention
Behavioral: Stress intervention
To evaluate psychological stress, participants will complete the Perceived Stress Scale, Beck Depression Inventory-Fast Screen, Anxiety Sensitivity Index-III, Posttraumatic Stress Diagnostic Scale and the Depression Anxiety Stress Scales; to evaluate cognitive and behavioral aspects of emotional avoidance, participants will complete the Emotional Avoidance Questionnaire as well as the Acceptance and Action Questionnaire, Difficulties in Emotion Regulation Scale, Illness Attitudes Scale and the Five Facet Mindfulness Questionnaire; and to evaluate quality of life in regards to his/her skin condition, participants will complete the Dermatology Life Quality Index questionnaire.
- Urticaria Activity Score [ Time Frame: 7 weeks ]Measures the daily level of skin itching and the number of hives as the study progresses.
- Level of stress. [ Time Frame: 7 weeks ]A set of questionnaires done before the first session and after the sixth/final session will be done to compare level of stress.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01111136
|United States, Mississippi|
|University of Mississippi Medical Center|
|Jackson, Mississippi, United States, 39216|
|Principal Investigator:||John W. Tole, D.O.||University of Mississippi Medical Center|
|Study Director:||Gailen D. Marshall, MD, PhD||University of Mississippi Medical Center|